Терапия рефрактерной сердечной недостаточности: литература

Baker DW, Konstam MA, Bottorff M, et al: Management of heart failure: I. Pharmacologic treatment. JAMA 272:1361, 1994. Review article of the drug therapy for heart failure due to left ventricular systolic dysfunction.

Burges R, Dodd MG, Gardiner DG: Pharmacologic profile of amlodipine. Am JCardiol64:101,1989. Reviews pharmacodynamics of the calcium channel blacker amlodipine.

Cody RJ, Kubo SH, Pickworth KK: Diuretic treatment for the sodium retention of congestive heart failure. Arch Intern Med 154:1905, 1994. Review article summarizing the rationale and current use of diuretics for the treatment of sodium retention and edema.

Ellison DH: The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann Intern Med 114:886, 1991. Reviews the sites and mechanisms of action of commonly used diuretics and combinations.

Gerlag PGG, van Meijel JJM: High-dose furosemide in the treatment of refractory heart failure. Arch Intern Med 148:286, 1988. Clinical study illustrating the successful use of high-dose furosemide to treat refractory heart failure in 35 human patients.

Hamlin RL, Nakayama T: Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles. J Vet Intern Med 12:93,1998. The IMPROVE Study Investigators: Clinical effects of enalapril maleate in dogs with naturally acquired heart failure: Results of the invasive multicenter prospective veterinary evaluation of enalapril. J Vet Intern Med 9:234,1995. Results of a blinded, placebo-controlled trial detailing the hemody-namic efficacy of enalapril.

Jugdutt BI, Khan MI, Jugdutt SJ, et al: Impact of left ventricular unloading after late reperfusion of canine anterior myocardial infarction on remodeling and function using isosorbide-5-mononitrate. Circulation 92:926, 1995. Research study demonstrating improved ventricular function and decreased remodeling in dogs with late reperfusion of acute anterior myocardial infarction treated with isosorbide-5-mononitrate.

McDonald KM, Francis GS, Matthews J, et al: Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. J Am Coll Cardiol 21:514,1993. Research study documenting attenuation of ventricular remodeling by long-term oral nitrate therapy in a dog model of discrete myocardial damage.

Packer M, O'Connor CM, Ghali JK: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335:1107, 1996. Results of a randomized, placebo-controlled trial of amlodipine in human heart failure.

Pitt D: ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES). Eur Heart J 16(SupplN):107,1995.

Wang W, McClain JM, Zucker IH: Aldosterone reduces baroreceptor discharge in the dog. Hypertension 19:270,1992.

Williams JF Jr, Bristow MR, Fowler MB, et al: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 26:1376, 1995.

Yamanaka K, Suzuki M, Ishiko J: Antihypertensive effects of amlodipine, a new calcium antagonist. Nippon Yakurigaku Zasshi 97:115,1991.